| Application no. and date | 04725035.2 (espacenet) (Federated) (European Patent Register), 20040401 | | Patent/reg. no. and date | DK/EP 1613599, 20101215 | | Publication date | 20060111 | | Priority no. and date | US 459724 P, 20030402 | | EP pub. no. and date |
EP 1613599 20060111 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 140993 | | Inventor | LOHSE, Olivier, 18, rue des Sapins
F-68170 Rixheim, FR,
PENN, Gerhard, Im Lohgraben 28
CH-4104 Oberwil, CH,
SCHILLING, Hanspeter, Falkenstrasse 12
CH-4103 Bottmingen, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | C07D 215/26 (2006.01) | | Title | Fremgangsmåde til fremstilling af 5-(halogenacetyl)-8-(substitueret oxy)-(1H)-quinolin-2-oner | | Int. application no. | EP2004003479 | | Int. publication no. | WO2004087668 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
